InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| Poly(I:C) (HMW) VacciGrade™ | Neoantigen vaccine-induced CD4 T cells confer protective immunity in a mouse ... | 2022 | J Immunother Cancer | Bekri S. et al. | DOI: 10.1136/jitc-2021-003572 |
| QUANTI-Blue™ | Herbo-metallic ethnomedicine 'Malla Sindoor' ameliorates lung inflammation in... | 2022 | J Ethnopharmacol. | Balkrishna A. et al. | DOI: 10.1016/j.jep.2022.115120 |
| Puromycin | LIM Tracker: a software package for cell tracking and analysis with advanced ... | 2022 | Sci Rep | Aramaki H. et al. | DOI: 10.1038/s41598-022-06269-6 |
| Poly(I:C) (HMW) VacciGrade™ | Multi-omics reveals mitochondrial metabolism proteins susceptible for drug di... | 2022 | Leukemia | Caplan M. et al. | DOI: 10.1038/s41375-022-01518-z |
| PHA-P | Adaptive NK cells undergo a dynamic modulation in response to human cytomegal... | 2022 | Bone Marrow Transplant | Basílio-Queirós D. et al. | DOI: 10.1038/s41409-022-01603-y |
| AddaVax™ | Heterotypic interactions drive antibody synergy against a malaria vaccine can... | 2022 | Nat Commun | Ragotte R.J. et al. | DOI: 10.1038/s41467-022-28601-4 |
| Primocin® | Syndecan-2 regulates PAD2 to exert antifibrotic effects on RA-ILD fibroblasts. | 2022 | Sci Rep | Tsoyi K. et al. | DOI: 10.1038/s41598-022-06678-7 |
| LPS-B5 (LPS from E. coli O55:B5) | Imaging of innate immunity activation in vivo with a redox-tuned PET reporter. | 2022 | Nat Biotechnol | Pisaneschi F. et al. | DOI: 10.1038/s41587-021-01169-y |
| Normocin® - Antimicrobial Reagent | Mitochondrial dysfunction associated with TANGO2 deficiency. | 2022 | Sci Rep | Heiman P. et al. | DOI: 10.1038/s41598-022-07076-9 |
| AddaVax™ | Enhancing neutralization of Plasmodium falciparum using a novel monoclonal an... | 2022 | Sci Rep | Knudsen A.S. et al. | DOI: 10.1038/s41598-022-06921-1 |
| Concanavalin A | An adjuvanted subunit SARS-CoV-2 spike protein vaccine provides protection ag... | 2022 | NPJ Vaccines | Tabynov K. et al. | DOI: 10.1038/s41541-022-00450-8 |
| Puromycin | Proteomic profiling reveals CDK6 upregulation as a targetable resistance mech... | 2022 | Nat Commun | Ng Y.L.D. et al. | DOI: 10.1038/s41467-022-28515-1 |
| Puromycin | The oral protease inhibitor (PF-07321332) protects Syrian hamsters against in... | 2022 | Nat Commun | Abdelnabi R. et al. | DOI: 10.1038/s41467-022-28354-0 |
| Zeocin® | The oral protease inhibitor (PF-07321332) protects Syrian hamsters against in... | 2022 | Nat Commun | Abdelnabi R. et al. | DOI: 10.1038/s41467-022-28354-0 |
| Hygromycin B Gold | The oral protease inhibitor (PF-07321332) protects Syrian hamsters against in... | 2022 | Nat Commun | Abdelnabi R. et al. | DOI: 10.1038/s41467-022-28354-0 |
| A549-Dual™ Cells | Comprehensive screening for drugs that modify radiation-induced immune respon... | 2022 | Br J Cancer | Okumura M. et al. | DOI: 10.1038/s41416-021-01688-0 |
| Puromycin | Drug screening and genome editing in human pancreatic cancer organoids identi... | 2022 | Cell Genom. | Hirt C.K. et al. | DOI: 10.1016/j.xgen.2022.100095 |
| Blasticidin | Drug screening and genome editing in human pancreatic cancer organoids identi... | 2022 | Cell Genom. | Hirt C.K. et al. | DOI: 10.1016/j.xgen.2022.100095 |
| HEK-Blue™ Selection | Helicobacter pylori binds human Annexins via Lipopolysaccharide to interfere ... | 2022 | PLoS Pathog. | Schmidinger B. et al. | DOI: 10.1371/journal.ppat.1010326 |
| QUANTI-Blue™ | Helicobacter pylori binds human Annexins via Lipopolysaccharide to interfere ... | 2022 | PLoS Pathog. | Schmidinger B. et al. | DOI: 10.1371/journal.ppat.1010326 |